SMTL ID : 4r5y.2 (1 other biounit)

The complex structure of Braf V600E kinase domain with a novel Braf inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 3.50 Å

Oligo State

monomer

Ligands

1 x 3K3: 5-({(1R,1aS,6bR)-1-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1a,6b-dihydro-1H-cyclopropa[b][1]benzofuran-5-yl}oxy)-3,4-dihydro-1,8-naphthyridin-2(1H)-one(Non-covalent)

3K3.1: 21 residues within 4Å: Chain A: I.32, V.40, A.50, K.52, E.70, V.73, L.74, I.82, L.83, I.96, T.98, Q.99, W.100, C.101, L.136, I.141, H.143, F.152, G.162, D.163, F.164 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:I.32, A:V.40, A:K.52, A:L.74, A:L.83, A:T.98, A:D.163, A:F.164, A:F.164 Hydrogen bonds: A:E.70, A:E.70, A:C.101, A:C.101, A:D.163

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Tang, Z. et al., BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in BRAF-Mutated Colorectal Cancers. Mol.Cancer Ther. (2015)

Release Date

2016-02-24

Peptides

Serine/threonine-protein kinase B-raf: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Serine/threonine-protein kinase B-raf

Related Entries With Identical Sequence